NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company's Lead Scientist and President of its StemVax Therapeutics Division

Stock Information for Novaccess Global Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novaccess Global Inc

NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
NovAccess Global Announces $10.7 Million Financing
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.